JP Stock MarketDetailed Quotes

4521 Kaken Pharmaceutical

Watchlist

3823.0
-20.0-0.52%

20min DelayMarket Closed Jun 7 15:00 JST

144.78BMarket Cap17.98P/E (Static)

Kaken Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

(Q1)Jun 30, 2022

Total revenue

-1.29%72.04B

-0.30%17.36B

-1.28%18.51B

-3.23%18.02B

-0.26%18.15B

-4.01%72.98B

-4.99%17.41B

-6.79%18.75B

-2.68%18.62B

-1.39%18.2B

Cost of revenue

0.23%33.51B

3.11%8.68B

-2.37%8.38B

0.98%8.36B

-0.77%8.09B

-2.99%33.43B

-4.00%8.42B

-5.75%8.58B

-1.62%8.28B

-0.24%8.16B

Gross profit

-2.57%38.54B

-3.49%8.68B

-0.34%10.14B

-6.60%9.66B

0.16%10.06B

-4.86%39.56B

-5.89%8.99B

-7.67%10.18B

-3.52%10.35B

-2.29%10.04B

Operating expense

-8.02%29.02B

-39.96%8.04B

13.17%6.78B

20.18%7.44B

13.02%6.76B

28.75%31.55B

109.83%13.39B

-2.89%5.99B

1.41%6.19B

2.22%5.98B

Staff costs

-0.99%7.12B

1.87%1.85B

-1.34%1.76B

-3.57%1.73B

-0.94%1.78B

-2.88%7.19B

-2.94%1.82B

-2.46%1.79B

-1.75%1.79B

-4.31%1.8B

Research and development costs

-20.56%12.54B

-57.37%4.04B

39.60%2.76B

36.43%3.14B

28.08%2.6B

87.52%15.79B

297.44%9.48B

-2.32%1.98B

7.33%2.3B

8.85%2.03B

Depreciation and amortization

8.93%317M

----

12.79%291M

----

-Depreciation

8.93%317M

----

12.79%291M

----

Other operating expenses

9.18%9.04B

1.61%1.83B

1.30%2.25B

22.65%2.58B

10.50%2.38B

-1.71%8.28B

-3.48%1.8B

-3.72%2.23B

-1.82%2.1B

2.18%2.15B

Operating profit

18.93%9.52B

114.59%641M

-19.69%3.36B

-46.54%2.22B

-18.80%3.3B

-53.11%8B

-238.35%-4.39B

-13.75%4.19B

-10.03%4.15B

-8.25%4.06B

Net non-operating interest income (expenses)

10.00%-9M

33.33%-2M

-50.00%-3M

0.00%-2M

33.33%-2M

9.09%-10M

25.00%-3M

0.00%-2M

0.00%-3M

Non-operating interest income

14.29%8M

0.00%2M

100.00%2M

16.67%7M

100.00%2M

0.00%2M

0.00%1M

Non-operating interest expense

0.00%17M

-20.00%4M

25.00%5M

0.00%4M

0.00%17M

0.00%5M

0.00%4M

Net investment income

-4.41%412M

75.00%7M

7.22%208M

-50.00%2M

-14.85%195M

20.06%431M

150.00%4M

22.01%194M

300.00%4M

9.05%229M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

69.23%-8M

55.56%-12M

-2,700.00%-26M

-2,800.00%-27M

Income from associates and other participating interests

Special income (charges)

91.26%-167M

94.98%-79M

-111.11%-19M

-700.00%-32M

88.54%-37M

47.79%-1.91B

58.50%-1.57B

18.18%-9M

-102.67%-4M

-7,975.00%-323M

Less:Other special charges

214.89%148M

300.00%60M

111.11%19M

700.00%32M

94.74%37M

-92.92%47M

-98.12%15M

-18.18%9M

102.67%4M

375.00%19M

Less:Write off

-98.98%19M

-98.78%19M

--0

-37.78%1.86B

-47.93%1.56B

--0

--304M

Other non-operating income (expenses)

-82.93%57M

-85.47%25M

-65.91%15M

-78.26%15M

-95.92%2M

158.91%334M

207.14%172M

100.00%44M

263.16%69M

53.13%49M

Income before tax

43.70%9.8B

109.89%576M

-19.27%3.56B

-47.71%2.21B

-13.90%3.45B

-50.90%6.82B

-918.18%-5.82B

-12.13%4.41B

-11.71%4.22B

-13.90%4.01B

Income tax

28.54%1.77B

63.36%-775M

-22.17%955M

-44.21%650M

-14.55%940M

-68.24%1.38B

-1,792.00%-2.12B

-18.04%1.23B

-18.07%1.17B

-14.86%1.1B

Net income

47.52%8.03B

136.40%1.35B

-18.15%2.61B

-49.04%1.56B

-13.66%2.51B

-43.03%5.44B

-432.14%-3.71B

-9.65%3.19B

-8.99%3.06B

-13.53%2.91B

Net income continuous operations

47.54%8.03B

136.42%1.35B

-18.15%2.61B

-49.05%1.56B

-13.65%2.51B

-43.03%5.44B

-432.14%-3.71B

-9.62%3.19B

-9.02%3.06B

-13.53%2.91B

Noncontrolling interests

Net income attributable to the company

47.52%8.03B

136.40%1.35B

-18.15%2.61B

-49.04%1.56B

-13.66%2.51B

-43.03%5.44B

-432.14%-3.71B

-9.65%3.19B

-8.99%3.06B

-13.53%2.91B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

47.52%8.03B

136.40%1.35B

-18.15%2.61B

-49.04%1.56B

-13.66%2.51B

-43.03%5.44B

-432.14%-3.71B

-9.65%3.19B

-8.99%3.06B

-13.53%2.91B

Gross dividend payment

Basic earnings per share

46.87%212.67

136.11%35.57

-18.89%68.92

-49.42%41.19

-12.90%66.99

-42.41%144.8

-447.89%-98.51

-8.80%84.97

-7.95%81.43

-12.38%76.91

Diluted earnings per share

46.87%212.67

135.94%35.57

-18.98%68.841

-49.42%41.19

-12.90%66.99

-42.41%144.8

-437.04%-98.9781

-8.80%84.97

-7.95%81.43

-12.38%76.91

Dividend per share

0.00%150

0.00%75

0.00%150

0.00%75

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022	(Q1)Jun 30, 2022
Total revenue	-1.29%72.04B	-0.30%17.36B	-1.28%18.51B	-3.23%18.02B	-0.26%18.15B	-4.01%72.98B	-4.99%17.41B	-6.79%18.75B	-2.68%18.62B	-1.39%18.2B
Cost of revenue	0.23%33.51B	3.11%8.68B	-2.37%8.38B	0.98%8.36B	-0.77%8.09B	-2.99%33.43B	-4.00%8.42B	-5.75%8.58B	-1.62%8.28B	-0.24%8.16B
Gross profit	-2.57%38.54B	-3.49%8.68B	-0.34%10.14B	-6.60%9.66B	0.16%10.06B	-4.86%39.56B	-5.89%8.99B	-7.67%10.18B	-3.52%10.35B	-2.29%10.04B
Operating expense	-8.02%29.02B	-39.96%8.04B	13.17%6.78B	20.18%7.44B	13.02%6.76B	28.75%31.55B	109.83%13.39B	-2.89%5.99B	1.41%6.19B	2.22%5.98B
Staff costs	-0.99%7.12B	1.87%1.85B	-1.34%1.76B	-3.57%1.73B	-0.94%1.78B	-2.88%7.19B	-2.94%1.82B	-2.46%1.79B	-1.75%1.79B	-4.31%1.8B
Research and development costs	-20.56%12.54B	-57.37%4.04B	39.60%2.76B	36.43%3.14B	28.08%2.6B	87.52%15.79B	297.44%9.48B	-2.32%1.98B	7.33%2.3B	8.85%2.03B
Depreciation and amortization	8.93%317M	----	----	----	----	12.79%291M	----	----	----	----
-Depreciation	8.93%317M	----	----	----	----	12.79%291M	----	----	----	----
Other operating expenses	9.18%9.04B	1.61%1.83B	1.30%2.25B	22.65%2.58B	10.50%2.38B	-1.71%8.28B	-3.48%1.8B	-3.72%2.23B	-1.82%2.1B	2.18%2.15B
Operating profit	18.93%9.52B	114.59%641M	-19.69%3.36B	-46.54%2.22B	-18.80%3.3B	-53.11%8B	-238.35%-4.39B	-13.75%4.19B	-10.03%4.15B	-8.25%4.06B
Net non-operating interest income (expenses)	10.00%-9M	33.33%-2M	-50.00%-3M	0.00%-2M	33.33%-2M	9.09%-10M	25.00%-3M	0.00%-2M	0.00%-2M	0.00%-3M
Non-operating interest income	14.29%8M	0.00%2M	0.00%2M	0.00%2M	100.00%2M	16.67%7M	100.00%2M	0.00%2M	0.00%2M	0.00%1M
Non-operating interest expense	0.00%17M	-20.00%4M	25.00%5M	0.00%4M	0.00%4M	0.00%17M	0.00%5M	0.00%4M	0.00%4M	0.00%4M
Net investment income	-4.41%412M	75.00%7M	7.22%208M	-50.00%2M	-14.85%195M	20.06%431M	150.00%4M	22.01%194M	300.00%4M	9.05%229M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets	69.23%-8M	55.56%-12M	0			-2,700.00%-26M	-2,800.00%-27M	0
Income from associates and other participating interests
Special income (charges)	91.26%-167M	94.98%-79M	-111.11%-19M	-700.00%-32M	88.54%-37M	47.79%-1.91B	58.50%-1.57B	18.18%-9M	-102.67%-4M	-7,975.00%-323M
Less:Other special charges	214.89%148M	300.00%60M	111.11%19M	700.00%32M	94.74%37M	-92.92%47M	-98.12%15M	-18.18%9M	102.67%4M	375.00%19M
Less:Write off	-98.98%19M	-98.78%19M	--0	--0	--0	-37.78%1.86B	-47.93%1.56B	--0	--0	--304M
Other non-operating income (expenses)	-82.93%57M	-85.47%25M	-65.91%15M	-78.26%15M	-95.92%2M	158.91%334M	207.14%172M	100.00%44M	263.16%69M	53.13%49M
Income before tax	43.70%9.8B	109.89%576M	-19.27%3.56B	-47.71%2.21B	-13.90%3.45B	-50.90%6.82B	-918.18%-5.82B	-12.13%4.41B	-11.71%4.22B	-13.90%4.01B
Income tax	28.54%1.77B	63.36%-775M	-22.17%955M	-44.21%650M	-14.55%940M	-68.24%1.38B	-1,792.00%-2.12B	-18.04%1.23B	-18.07%1.17B	-14.86%1.1B
Net income	47.52%8.03B	136.40%1.35B	-18.15%2.61B	-49.04%1.56B	-13.66%2.51B	-43.03%5.44B	-432.14%-3.71B	-9.65%3.19B	-8.99%3.06B	-13.53%2.91B
Net income continuous operations	47.54%8.03B	136.42%1.35B	-18.15%2.61B	-49.05%1.56B	-13.65%2.51B	-43.03%5.44B	-432.14%-3.71B	-9.62%3.19B	-9.02%3.06B	-13.53%2.91B
Noncontrolling interests	0	0	0	0	0			0	0	0
Net income attributable to the company	47.52%8.03B	136.40%1.35B	-18.15%2.61B	-49.04%1.56B	-13.66%2.51B	-43.03%5.44B	-432.14%-3.71B	-9.65%3.19B	-8.99%3.06B	-13.53%2.91B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	47.52%8.03B	136.40%1.35B	-18.15%2.61B	-49.04%1.56B	-13.66%2.51B	-43.03%5.44B	-432.14%-3.71B	-9.65%3.19B	-8.99%3.06B	-13.53%2.91B
Gross dividend payment
Basic earnings per share	46.87%212.67	136.11%35.57	-18.89%68.92	-49.42%41.19	-12.90%66.99	-42.41%144.8	-447.89%-98.51	-8.80%84.97	-7.95%81.43	-12.38%76.91
Diluted earnings per share	46.87%212.67	135.94%35.57	-18.98%68.841	-49.42%41.19	-12.90%66.99	-42.41%144.8	-437.04%-98.9781	-8.80%84.97	-7.95%81.43	-12.38%76.91
Dividend per share	0.00%150	0.00%75	0	0.00%75	0	0.00%150	0.00%75	0	0.00%75	0
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall